Skip to main content



  • Thursday, May 9th
    11:00 AM – 12:00 PM CDT
    Oral Abstract Presentations
    Moderator: David Lieb, MD, FACP, FACE – Eastern Virginia Medical School
  • Thursday, May 9th
    11:00 AM – 11:15 AM CDT
    Descriptive Analysis of Inpatient Sodium Glucose Co-Transporter 2 Inhibitor Use
    Location: Collaboration Station, Empire Ballroom, Level 2
    Diabetes
  • Thursday, May 9th
    11:15 AM – 11:30 AM CDT
    Efficacy of a Non-Invasive Blood Glucose Monitor for Diabetes Management Using a Radiofrequency Sensor and Machine Learning
    Location: Collaboration Station, Empire Ballroom, Level 2
    Poster Presenter: Dominic Klyve, PhD
    Diabetes
  • Thursday, May 9th
    11:30 AM – 11:45 AM CDT
    Integrated system biology approaches to identify biomarker and shared molecular pathways for type 2 diabetes and coronary artery disease patients
    Location: Collaboration Station, Empire Ballroom, Level 2
    Poster Presenter: Md. Zubbair Malik, PhD (he/him/his) – Dasman Diabetes Institute, Kuwait
    Diabetes
  • Thursday, May 9th
    11:45 AM – 12:00 PM CDT
    The Impact of Digital Twin Technology on HbA1c Reduction and ASCVD Risk in Participants Enrolled for Type 2 Diabetes Remission: Outcomes of RCCT At 1 Year
    Location: Collaboration Station, Empire Ballroom, Level 2
    Poster Presenter: Paramesh Shamanna, MD – Bangalore Diabetes Centre
    Cardiometabolic and Lipids
  • Thursday, May 9th
    1:45 PM – 2:30 PM CDT
    Oral Abstract Presentations
    Moderator: Thanh D. Hoang, DO, FACP, FACE, Professor of Medicine (he/him/his) – Walter Reed National Military Medical Center
  • Thursday, May 9th
    1:45 PM – 2:00 PM CDT
    Efficacy of Teprotumumab in Phenotype Type I vs Type II Thyroid Eye Disease
    Location: Learning Zone, Empire Learning Lab, Level 2
    Thyroid
  • Thursday, May 9th
    2:00 PM – 2:15 PM CDT
    Thyrotoxicosis-Induced Hypercalcemia: A Rare Confluence of Endocrine Disorders
    Location: Learning Zone, Empire Learning Lab, Level 2
    Poster Presenter: Trang Tran
    Thyroid
  • Thursday, May 9th
    2:15 PM – 2:30 PM CDT
    Weight reduction over time in tirzepatide-treated participants by early weight loss response – post hoc analysis in SURMOUNT-1
    Location: Learning Zone, Empire Learning Lab, Level 2
    Poster Presenter: Kimberly Gudzune, MD, MPH (she/her/hers) – Johns Hopkins University School of Medicine
    Nutrition and Obesity
  • Friday, May 10th
    11:00 AM – 11:15 AM CDT
    Baseline Characteristics of Adults with Classic Congenital Adrenal Hyperplasia Enrolled in CAHtalyst, a Phase 3 Study of Crinecerfont, a Corticotropin-Releasing Factor Type 1 Receptor Antagonist
    Location: Collaboration Station, Empire Ballroom, Level 2
    Poster Presenter: Oksana Hamidi, DO – University of Texas Southwestern Medical Center
    PGAN
  • Friday, May 10th
    11:15 AM – 11:30 AM CDT
    Impact of Adrenalectomy on Bone Density and Quality in Patients with Mild Autonomous Cortisol Secretion: A Prospective Longitudinal Cohort Study
    Location: Collaboration Station, Empire Ballroom, Level 2
    Poster Presenter: Jasmine Saini, MBBS
    PGAN
  • Friday, May 10th
    11:30 AM – 11:45 AM CDT
    Association Between Serum Lipoprotein (a), NAFLD and Risk of Non-fatal Myocardial Infarction in Individuals with Diabetes Mellitus
    Location: Collaboration Station, Empire Ballroom, Level 2
    Poster Presenter: Avica Atri, MD (she/her/hers) – Jefferson Albert Einstein Medical Center
    Cardiometabolic and Lipids
  • Friday, May 10th
    11:45 AM – 12:00 PM CDT
    Oral Semaglutide helps in maintaining β-cell function in patients with Recent-Onset Latent Autoimmune Diabetes in Adults: a 6 months Prospective Study
    Location: Collaboration Station, Empire Ballroom, Level 2
    Poster Presenter: Sharvil Suresh Gadve, MD, MBBS, DM (he/him/his) – Excel Endocrine Centre, Kolhapur
    Diabetes